📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Silk nanoparticles: proof of lysosomotropic anticancer drug delivery at single-cell resolution. (2017)

First Author: Totten JD

Attributed to: Future Continuous Manufacturing and Advanced Crystallisation Research Hub funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/1061186x.2017.1363212

PubMed Identifier: 28812388

Publication URI: http://europepmc.org/abstract/MED/28812388

Type: Journal Article/Review

Volume: 25

Parent Publication: Journal of drug targeting

Issue: 9-10

ISSN: 1026-7158